Retinol and tretinoin: which one actually works better?

Why tretinoin has the stronger track record

Bottom line: tretinoin is the reference standard, and retinol is the less proven option. Retinol has to be converted through retinaldehyde into tretinoin before it does anything, a two-step process described in a review of topical antiaging retinoids.

An older estimate put retinol at roughly 20 times lower potency than tretinoin, according to an overview of retinoids and skin aging. Treat that number as dated. We did not find a recent matched-dose trial that confirms it.

Cosmetic retinoids also skip the premarket efficacy testing that prescription drugs must pass. That is the main reason the 'anti-wrinkle' label on an OTC serum tells you less than it sounds like it does.

Irritation: where retinol has the edge

Bottom line: retinol is usually easier on skin, but the evidence for that is mostly small. The 'retinoid reaction' of itching, burning, redness and peeling is more common with tretinoin, is dose-dependent, and usually fades with time, according to a literature review on retinoids before resurfacing.

In a very small study of six people over 14 days, retinol caused less transepidermal water loss, erythema and scaling than retinoic acid did, per the aging overview. Six participants is not enough to settle anything, so treat it as a hint.

The most relevant head-to-head trial is an exploratory randomized trial in moderate-to-severe photodamage. It compared a 1.1% 'triple tretinoin precursor' cosmetic product with 0.02% tretinoin over 24 weeks, as reported in JAMA Dermatology. The precursor product caused erythema about six times less often, even though it contained more tretinoin equivalent.

Tretinoin dosing: stronger is not always better

Bottom line: 0.05% applied nightly is the standard dose. Prescription strengths range from 0.01% to 0.1%, with 0.025%, 0.05% and 0.1% most common, according to a review of retinoids for facial resurfacing and a focused review of topical antiaging retinoids.

• Two randomized trials found 0.05% beat 0.01% on wrinkle effacement.
• A 24-month trial found no clinical difference between 0.02% and 0.05%.
• Lower strengths give less pronounced gains but fewer side effects.
• Long-term use of 0.05% has been reported as safe and effective.

In practice, that means the lowest strength that works for you is often the right one. A stronger bottle is not automatically a better result.

The weak spots: small, old or industry-funded

Bottom line: the comparison data are thin, and the industry-linked data are the least reliable. In acanthosis nigricans, 0.025% tretinoin cream outperformed 10% and 4% retinol peels on severity scores, while the 4% peel caused the fewest side effects, according to a study of acanthosis nigricans treatments. That trial has roughly 11 participants per arm, so it is very low-powered.

A patent filing reports that 12 weeks of retinol serum and tretinoin showed parity on most endpoints, with retinol softening skin faster at week 4 and cutting water loss by 16%, per a transdermal delivery patent. A patent is not a peer-reviewed trial, so we would not rely on it.

We found no systematic review or meta-analysis comparing the two directly. We also found no professional-society guidance from groups such as the AAD on combining them or switching between them.

Safety, and who should skip tretinoin

Bottom line: tretinoin is prescription-only, and pregnant people should avoid it. Cleveland Clinic describes it as stronger and faster-acting than OTC retinol, and notes that it is used for melasma.

Tretinoin is teratogenic in animals at doses hundreds to a thousand times the topical human dose, according to a National Cancer Institute trial protocol. It is contraindicated in people sensitive to vitamin A or other retinoids. Where tretinoin causes too much irritation, adapalene or tazarotene are alternatives, per the resurfacing review.

If you are weighing the over-the-counter side, our retinol guide covers what the cosmetic label can and cannot promise.